We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





Ultrasensitive Troponin-I Assay to Be Introduced at the AACC Clinical Lab Expo

By LabMedica International staff writers
Posted on 01 Aug 2013
An advanced rapid assay for the heart attack biomarker troponin-I is being introduced to American cardiac researchers and clinicians at the AACC (American Association for Clinical Chemistry) Clinical Lab Expo in Houston (TX, USA), from July 30-August 1, 2013.

Abbot Diagnostics (Abbot Park, IL, USA) will be demonstrating the ARCHITECT High Sensitive Troponin-I (hsTnI) assay at the Clinical Lab Expo. More...
In a study recently completed at Brigham and Women’s Hospital (Boston, MA, USA) this test was compared to a fourth generation troponin T assay among 4,695 patients presenting with severe chest pain.

Results revealed that the ARCHITECT hsTnI assay could detect very low levels of troponin-I, which allowed doctors to evaluate whether or not patients were having a heart attack within two to four hours after presentation. Furthermore, the test was so sensitive that doctors were able to predict which patients presenting with symptoms of a heart attack, such as severe chest pain, were at a higher risk for having a heart attack up to 30 days later.

"This study adds to the clinical evidence confirming the advantages of Abbott’s high sensitive troponin test to provide more insight to clinicians about which patients are at greater risk for a future heart attack as compared to contemporary tests," said Dr. John Frels, divisional vice president, diagnostics research at Abbott Diagnostics. "This is important information for patient care because it may help doctors focus on the patients at greater risk for appropriate management."

The ARCHITECT hsTnI assay – already being marketed in Europe – was designed to run on Abbott’s automated ARCHITECT family of analyzers.

Related Links:
Abbot Diagnostics



Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
New
Whole Blood Control
Lyphochek Whole Blood Control
New
Varicella Zoster Virus Assay
LIAISON VZV Assay Panel (IgG HT, IgM)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: New biomarkers could someday make it easy to spot Parkinson’s disease in a patient’s blood sample (Photo courtesy of Shutterstock)

Unique Blood-Based Genetic Signature Can Diagnose Parkinson’s Disease

Parkinson's disease is primarily recognized for its impact on the central nervous system. Recent scientific progress has shifted focus to understanding the involvement of the immune system in the onset... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: Custom hardware and software for the real-time detection of immune cell biophysical signatures in NICU (Photo courtesy of Pediatric Research, DOI:10.1038/s41390-025-03952-y)

First-Of-Its-Kind Device Profiles Newborns' Immune Function Using Single Blood Drop

Premature infants are highly susceptible to severe and life-threatening conditions, such as sepsis and necrotizing enterocolitis (NEC). Newborn sepsis, which is a bloodstream infection occurring in the... Read more

Pathology

view channel
Image: The innovative doublet configuration and annular illumination overcome traditional metalens limitations (Photo courtesy of Tao Li and Jiacheng Sun/Nanjing University)

High-Resolution Metalens Doublet Microscope to Enhance Diagnostic Capabilities

Metalenses mark a groundbreaking leap in optical technology. Unlike traditional microscope objectives that rely on curved glass surfaces, metalenses utilize nanoscale structures to manipulate light at... Read more

Technology

view channel
Image: Concept of biosensor integrated into hygiene pads enabling direct semi-quantitative analysis of biomarkers in unprocessed menstruation blood (Photo courtesy of Dosnon, L et al. DOI: 10.1002/advs.202505170)

First Ever Technology Recognizes Disease Biomarkers Directly in Menstrual Blood in Sanitary Towels

Over 1.8 billion people menstruate worldwide, yet menstrual blood has been largely overlooked in medical practice. This blood contains hundreds of proteins, many of which correlate with their concentration... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.